1 billion heavy chewing tablets Hainan Miaoyinchun Pharmaceuticals will enter the game

Medical Network May 18 hearing May 13, Hainan Miu Spring generic pharmaceuticals to class 6 Declaration of aluminum magnesium carbonate chewable tablets change in the trial state is "Accreditation completed - go this document." Meters within the network data show that in 2019 domestic sales of aluminum magnesium carbonate chewable tablets (Chinese urban public medical institutions and retail pharmacies end total retail price) more than one billion yuanHydrotalcite chewable antacid gastric mucosa belonging to a class of protection, having a unique macromolecular network structure layer, can rapidly improve or alleviate a variety of disorders caused by hyperacidity, clinically for gastric and duodenal ulcers, acute and chronic gastritis, bile reflux gastritisFIG1: 2015--2019 years domestic sales hydrotalcite chewable tablets (unit: million)m data network, in recent years Hydrotalcite chewable tablets Chinese public medical institutions terminal sales rose year by year, while retail salescity terminal is fluctuated, 2019, total sales of 1.014 billion yuan, an increase of 5.26%In addition to original research manufacturers Bayer, currently has 31 domestic pharmaceutical companies have aluminum magnesium carbonate chewable tablets production approval, in the end the competitive landscape Chinese public medical institutions in 2019, Bayer products exclusively for nearly 90% of the market a large share of space, the generic alternative to the original researchFIG2: Hydrotalcite chewable consistencymeters assess the progress data network, Chongqing Watson Pharmaceuticals, Zhejiang Hangzhou Kang Pharmaceutical submitted Hydrotalcite chewable tablets consistency evaluation of supplemental applications, including Chongqing Watson pharmaceutical's products have been successfully through the evaluation; Nanning Baihui pharmaceutical Group, 9 Code Hunan pharmaceutical, Guangdong Huarun Shun Feng medicine to new Classified newspaper production, including Guangdong Huarun Shun Feng pharmaceutical the products have been approved on the market, deemed by conformance assessmentSource: databasemeters within the network Note: The statistics as of May 15, if imperfect, please correct me!